Business & Industry

In this introduction to our project, “Fifty Years After: Black Employment in the United States Under the Equal Employment Opportunity Commission,” we outline the socioeconomic forces behind the promising rise and disastrous fall of an African American blue-collar middle class.

This paper considers the relationship between profits realized from higher insulin list prices, pharmaceutical innovation, and the financial structures of the three dominant insulin manufacturing companies, which set list prices.

The scale of firm exposure to the coronavirus is unprecedented by earlier outbreaks, spans all major economies and is pervasive across all industries

As Covid-19 spreads globally in the first quarter of 2020, this paper finds that firms’ primary concerns relate to the collapse of demand, increased uncertainty, and disruption in supply chains

William Lazonick emphasizes that keeping workers productively employed is key to economic recovery from Covid-19 as well as a healthy economic future

It’s time for business executives, employees, and taxpayers to come together to help get us out of the pandemic and create conditions for a sustainable and equitable future

New research points to critical role of public funding in drug discoveries and development for the last decade

Prof. Oliver Hart will deliver the inaugural talk on Corporate Purpose

Brexit uncertainty has already taken an economic toll

Using tools from computational linguistics, we construct new measures of the impact of Brexit on listed firms in the United States and around the world

Stock buybacks are giveaways for greedy investors at the expense of everyone else.

Pharmaceutical drugs are often a matter of life or death. It should be a prime objective of government policy to rid the industry of financialization.

To make start-ups work for everyone, we need to put power back in the hands of workers.

Big Tech companies are swallowing up nascent competitors. Why aren’t regulators paying attention?

How antitrust law is ill-equipped to address tech mergers